Kate Mitchell
Lecturer in Public Health (GCU London)
GCU London
Kate Mitchell is a Lecturer in Public Health, and teaches on the Master of Public Health course at GCU London.
Kate has an MSc in modern epidemiology and a PhD in immuno-epidemiology, and was previously a Research Fellow at the London School of Hygiene and Tropical Medicine and then at Imperial College London.
Kate has expertise in mathematical modelling of infectious disease transmission and control. Much of her recent research has focussed on HIV transmission among key populations, including men who have sex with men, in India, Nigeria, China and the United States.
Research Outputs
Output by category
Contributions to Journals
arrow_forward
2020
Identifying regions of greatest need for ending the HIV epidemic: a plan for America
Mia Moore, Marie Claude Boily, Kate M. Mitchell et al.
In: Journal of Acquired Immune Deficiency Syndromes,
Vol. 85,
No. 4,
2020, p. 395-398.
https://doi.org/10.1097/QAI.0000000000002477
2019
HIV Research for Prevention 2018: From research to impact conference summary and highlights
Barbara L. Shacklett, Julià Blanco, Lisa Hightow-Weidman et al.
In: AIDS Research and Human Retroviruses,
Vol. 35,
No. 7,
2019, p. 598-607.
https://doi.org/10.1089/aid.2019.0074
2013
Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis
Claire D. Bourke, Norman Nausch, Nadine Rujeni et al.
In: Journal of Infectious Diseases,
Vol. 208,
No. 1,
2013, p. 159-169.
https://doi.org/10.1093/infdis/jis524
2012
Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms
Kate M. Mitchell, Francisca Mutapi, Nicholas J. Savill et al.
In: Proceedings of the National Academy of Sciences of the United States of America,
Vol. 109,
No. 33,
2012, p. 13347-13352.
https://doi.org/10.1073/pnas.1121051109
Output by date
2026
arrow_forward
2025
arrow_forward
2024
arrow_forward
2023
arrow_forward
2022
arrow_forward
2021
arrow_forward
2020
arrow_forward
Identifying regions of greatest need for ending the HIV epidemic: a plan for America
Mia Moore, Marie Claude Boily, Kate M. Mitchell et al.
In: Journal of Acquired Immune Deficiency Syndromes,
Vol. 85,
No. 4,
2020, p. 395-398.
https://doi.org/10.1097/QAI.0000000000002477
2019
arrow_forward
HIV Research for Prevention 2018: From research to impact conference summary and highlights
Barbara L. Shacklett, Julià Blanco, Lisa Hightow-Weidman et al.
In: AIDS Research and Human Retroviruses,
Vol. 35,
No. 7,
2019, p. 598-607.
https://doi.org/10.1089/aid.2019.0074
2018
arrow_forward
2017
arrow_forward
2016
arrow_forward
2015
arrow_forward
2014
arrow_forward
2013
arrow_forward
Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis
Claire D. Bourke, Norman Nausch, Nadine Rujeni et al.
In: Journal of Infectious Diseases,
Vol. 208,
No. 1,
2013, p. 159-169.
https://doi.org/10.1093/infdis/jis524
2012
arrow_forward
Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms
Kate M. Mitchell, Francisca Mutapi, Nicholas J. Savill et al.
In: Proceedings of the National Academy of Sciences of the United States of America,
Vol. 109,
No. 33,
2012, p. 13347-13352.
https://doi.org/10.1073/pnas.1121051109
2011
arrow_forward
2008
arrow_forward
